Denmark
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -5.76 B
|
Dec. 31, 2023 | USD 86.17 | 4.52% |
|
Denmark |
|
2 |
USD -144.68 M
|
Dec. 31, 2023 | USD 24.06 | 1.57% |
|
Denmark |
|
3 |
USD -3.52 M
|
Dec. 31, 2023 | USD 102.45 | 7.03% |
|
Denmark |
|
4 |
USD -2.70 M
|
Dec. 31, 2023 | USD 130.66 | 2.64% |
|
Denmark |
|
5 |
USD -198.88 K
|
Dec. 31, 2023 | USD 2.73 | 4.48% |
|
Denmark |
|
6 |
USD -87.00 K
|
Dec. 31, 2023 | USD 2.46 | -0.40% |
|
Denmark |
The Vaccines company in Denmark with the highest Capital Expenditure is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD -5.76 B.
The Vaccines company in Denmark with the lowest Capital Expenditure is Evaxion Biotech A/S (NasdaqCM: EVAX) at USD -87.00 K.
The top 10 Vaccines companies in Denmark by Capital Expenditure are Novo Nordisk A/S, Bavarian Nordic A/S, Zealand Pharma A/S, Ascendis Pharma A/S, ExpreS2ion Biotech Holding AB (publ) and Evaxion Biotech A/S.
The bottom 10 Vaccines companies in Denmark by Capital Expenditure are Evaxion Biotech A/S, ExpreS2ion Biotech Holding AB (publ), Ascendis Pharma A/S, Zealand Pharma A/S, Bavarian Nordic A/S and Novo Nordisk A/S.